Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.
Innovatie en intellectueel eigendom · 24-2-20231 min lezen
Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
The United States Patent and Trademark Office (USPTO), Department of Commerce, in collaboration with the United States Food and Drug Administration (FDA), Department of Health and Human Services, is extending the written comment period for the notice titled "Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments" that was published in the Federal Register on November 7, 2022, until March 10, 2023.
Oorspronkelijke brontaal: Federal Register — Patent and Trademark OfficeOrigineel bericht openen →